Search Results

Containing any of the words

Only of the type

"PROSPECTIVE, RANDOMIZED, OPEN LABEL CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF DEXMEDETOMIDINE USE BEYOND 24 HOURS COMPARED WITH MIDAZOLAM IN CHILDREN ADMITTED TO PEDIATRIC INTENSIVE CARE UNIT (PICU) AT KASCH-MNGHA. (PROMISE)" Drug Clinical Trial

Prospective, Randomized, Open label Controlled trial to evaluate the safety and efficacy of Dexmedetomidine use beyond 24 horse Compared with Midazolam in children admitted to Pediatric Intensive Care unit (PICU) at KASCH-NGHA Drug Clinical Trial

Addition of Neutral Protamine Lispro Insulin or Insulin Glargine to Oral Type 2 Diabetes Regimens for Patients with Suboptimal Glycemic Control Awareness Article

An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900, an Oral Plasma Kallikrein Inhibitor, for On-demand Treatment of Angioedema Attacks in Adolescent and Adult Patients with Hereditary Angioedema Type I or II Drug Clinical Trial

Once-daily basal Insulin Glargine versus thrice-daily Prandial Insulin Lispro in people with type 2 diabetes on oral hypoglycemic agents Awareness Article

In an Online Questionnaire launched by SFDA: 73% of respondents are not keen to report about counterfeit or expired products News

Influenza vaccine (intranasal, live attenuated) (LAIV trivalent): Influenza Virus Type A H1N1, Influenza Virus Type A H3N2, Influenza Virus Type B (Victoria lineage) New SFDA Drug Approvals

An open-label extension trial of the long-term safety and efficacy of BI 1015550 taken orally in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) (FIBRONEER™-ON) Drug Clinical Trial

SFDA" Eliminates Manipulation of imported food products specifications via electronic registration of 600 Thousand Products Warnings

(SG-1808-19-H) Urgent FSN’s of THERA-Trainer balo, BALANCE-Trainer, THERA-Trainer verto Manufactured by Medica Medizintechnik GmbH Medical Report